The influence of Bi-Level Positive Airway Pressure ventilation on lipid level in patients with chronic heart failure of coronary heart disease
10.3760/cma.j.issn.1008-6706.2010.01.023
- VernacularTitle:双水平气道正压通气对冠心病并慢性心力衰竭患者血脂的影响
- Author:
Chunyun ZHANG
;
Yimin CHEN
- Publication Type:Journal Article
- Keywords:
Positive pressure ventilation;
Coronary disease;
Chronic heart failure;
Blood lipid
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(1):48-49
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the influence of BiPAP on lipid level in patients with chronic heart failure of coronary heart disease.Methods 20 patients with chronic heart failure of coronary heart disease were taken BiPAP:Blood samples were taken from forearm vein before and 4 weeks and 12 weeks after treatment,the lipid level was measured and compared.Results The observation group of The coronary heart disease with chronic heart failure in pre-treatment serum level of total cholesterol(TC)(7.47±0.12)mmol/L,triglycerides(TG)(3.52±0.13)mmol/L,low-density lipoprotein cholesterol(LDLc)(3.73 ±0.11)nmmol/L,apolipoprotein-B(Apo-B)(1.37±0.02)g/Lwere significantly lower than 14 weeks after treatment TC(4.5±0.03)mmol/L,TG(2.6±0.02)mmol/L,LDLc(2.8±0.06)mmol/L,Apo-B(1.02±0.02)g/L)(t=2.154,t=2.278,t=2.311,t=2.347,P all<0.05) in coronary heart disease with chronic heart failure;The observation group after treatment 14 weeks of HDL-CH(1.45±0.02)mmol/Land Apo-A(1.21±0.03)g/L lower than before treatment HDLc(1.05±0.01)mmol/L,Apo-A(0.87±0.01)g/L(t=2.234,t=2.318,P all<0.05) in coronary heart disease with chronic heart failure.Conclusion BiPAP therapy could effectively to ameliorate lipid metabolism in patients with chronic heart failure of coronary heartdisease in the long term.
